Search

Displaying results 6901 - 6910 of 8468 in total

Drug
Creatinolfosfate
go.drugbank.com/drugs/DB13071
Investigational
COP has been investigated for the treatment of Diabetic Retinopathy.
Drug
Dipropyl-4-hydroxytryptamine
go.drugbank.com/drugs/DB13990
Experimental
Dipropyl-4-hydroxytryptamine was first synthesized by Alexander Shulgin. This agent and its properties haven't been fully elucidated.
Drug
(5Z,7E,9)-decatrien-2-one
go.drugbank.com/drugs/DB15619
Investigational
Similar to [(5E,7E,9)-decatrien-2-one], it has a strong pineapple aroma.[A191116]
Drug
Gadoxetic acid
go.drugbank.com/drugs/DB08884
ApprovedInvestigational
[A263156] Gadoxetate is a unique gadolinium-based contrasting agent (GBCA) with both dynamic phase and hepatobiliary phase and thus has different pharmacokinetic and pharmacodynamic properties compared
Drug
Copper histidinate
go.drugbank.com/drugs/DB32041
Approved
It was approved by the US FDA in January 2026 for the treatment of pediatric patients with Menkes disease.[L54993,L54998]
Drug
Lemborexant
go.drugbank.com/drugs/DB11951
ApprovedInvestigational
[L10863] Recent research in the field of sleep disorders has revealed that insomnia is likely driven not by the inability of the brain to "switch on" sleep-related circuits, but rather an inability to
Drug
Ultevursen
go.drugbank.com/drugs/DB17835
Investigational
It was developed by ProQR Therapeutics and is being investigated for the treatment of retinitis pigmentosa.
Drug
Lagociclovir
go.drugbank.com/drugs/DB21266
Experimental
Lagociclovir has a monoisotopic molecular weight of 269.09 Da.
Drug
Garvagliptin
go.drugbank.com/drugs/DB21280
Experimental
Garvagliptin has a monoisotopic molecular weight of 399.14 Da.
Drug
Cimpuciclib
go.drugbank.com/drugs/DB21499
Experimental
Cimpuciclib has a monoisotopic molecular weight of 542.29 Da.